Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? | Zendy

Helmi L. Lutsep | Zendy; Michael Lynn | Zendy; George Cotsonis | Zendy; Colin P. Derdeyn | Zendy; Tanya N. Turan | Zendy; David Fiorella | Zendy; L. Scott Janis | Zendy; Bethany F Lane | Zendy; Jean Montgomery | Zendy; Marc I. Chimowitz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?

Author(s) -

Helmi L. Lutsep,

Michael Lynn,

George Cotsonis,

Colin P. Derdeyn,

Tanya N. Turan,

David Fiorella,

L. Scott Janis,

Bethany F Lane,

Jean Montgomery,

Marc I. Chimowitz

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.009846

Subject(s) - medicine , stenosis , stroke (engine) , angioplasty , cardiology , randomized controlled trial , surgery , mechanical engineering , engineering

Although the Stenting Versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial showed that medical therapy alone was superior to stenting plus medical therapy for preventing recurrent strokes in patients with symptomatic intracranial stenosis, we determined whether SAMMPRIS supported the use of stenting in any subpopulations of patients with symptomatic intracranial arterial stenosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research